cidirol 1 mg/ml oestradiol benzoate injection
genetics australia co-operative ltd - oestradiol benzoate - endocrine system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - fertility problems | synchronisation of oestrus & ovulation | anoestrus | oestrus cycle | ovarian cysts
synovex s steer growth and finishing implants
zoetis australia pty ltd - oestradiol benzoate; progesterone; detectable marker - parenteral implant, device - oestradiol benzoate steroid-estrogen active 20.0 mg/im; progesterone steroid-progestin active 200.0 mg/im; detectable marker miscellaneous other 0.0 p - nutrition & metabolism - steer (castrated male cattle) | beef | bovine | bullock (young) | male cattle - castrated - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
estradiol transdermal system- estradiol patch
alvogen, inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.025 mg in 1 d - when prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, topical vaginal products should be considered. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medication should be carefully considered. the estradiol transdermal system is contraindicated in women with any of the following conditions: the estradiol transdermal system should not be used during pregnancy [see contraindications (4)] . there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins as oral contraceptives inadvertently during early pregnancy. the estradiol transdermal system should not be used during lactation. estrogen administration to nursing women has been shown to decrease the quantity and quality of the breast milk. detectable amounts of estrogens have been identified in the b
delestrogen- estradiol valerate injection
par pharmaceutical, inc. - estradiol valerate (unii: okg364o896) (estradiol - unii:4ti98z838e) - estradiol valerate 10 mg in 1 ml - delestrogen (estradiol valerate injection, usp) is indicated in the: 1. treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. 4. treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). delestrogen should not be used in women with any of the following conditions: 1. undiagnosed abnormal genital bleeding. 2. known, suspected, or history of cancer of the breast. 3. known or suspected estrogen-dependent neoplasia. 4. active deep vein thrombosis, pulmonary embolism or a history of these conditions. 5. active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). 6. liver dysfunction or disease. 7. delestrogen should not be used in patients with known hypersensitivity to its ingredients. 8. known or suspected pregnancy. there is no indication for delestrogen in pregnancy. there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy [see precautions ].
oestradiol benzoate s.a. oestrogen for intramuscular or subcutaneous injection
intervet australia pty limited - oestradiol benzoate - endocrine system - cat - male (tom) | cow | dog - female (bitch) | dog - male | goat doe (female) | horse mare (female) | pig sow (female) | sheep - metritis | misalliance | prostate hyperplasia | pyometra | sub oestrus | urinary incontinence (spayed bitch) | incontinence | silent heat
oestradiol benzoate capsules for use only with eazi-breed cidr b progesterone
rab australia p/l - oestradiol benzoate - endocrine system - cow | bovine | female cattle - sex hormones | abortion | anoestrus | controlled breeding | luteolytic agent | oestrus control | oestrus induction
oestradiol benzoate oestrogen for intramuscular or subcutaneous injection
intervet australia pty limited - oestradiol benzoate - endocrine system - cat - male (tom) | cow | dog - female (bitch) | dog - male | goat | horse mare (female) | pig sow (female) | sheep | billy | bit - anal adenomata | mesalliance | metritis | modify hypersexuality | prostate hyperplasia | prostatitis | pyometra | sub oestrus | urinary incontinence (spayed bitch) | excess libido - reduce | incontinence | silent heat
estradiol sun 10 micrograms vaginal tablets
sun pharmaceutical industries europe b.v. - estradiol - vaginal tablet - 10 microgram(s) - estradiol
rizatriptan benzoate tablet
heritage pharmaceuticals inc. - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan 5 mg - rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. limitations of use - rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks. - rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see contraindications (4)] . - rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of rizatriptan benzoate tablets has not been established for cluster headache rizatriptan benzoate tablets are contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, histo
ethinylestradiol/drospirenone leon farma & placebo 0.03 mg/3 mg film-coated tablets
laboratorios leon farma, s.a. - ethinylestradiol; drospirenone - film-coated tablet - 0.03/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol